Segments Covered:
The report segments the global peptide therapeutics market by drug class, by route of administration, by
technology and by region. Based on drug class segment includes luteinizing hormone (LH)-releasing hormone
(LHRH), somatostatins, glucagon and analogs, insulins, vasopressin, calcitonins and other. Based on route of
administration the segment is divided into oral, parental and others. Technology segment includes liquid
phase, solid phase and hybrid phase.
Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/956
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography is provided over the
period of 2017 – 2023.
Globally North America is the largest market for peptide therapeutics market accounted for market shares of
more than 40% in 2015. The region anticipated to retain its dominance throughout the forecasted period
driven by advanced healthcare infrastructure in this region. Moreover, Presence of established players in this
region contributed significantly in the regional growth. Following North America, Europe stands second in the
global market including major markets such as Germany, Spain, Netherland and UK. Emergence of
pharmaceutical and biotech companies, massive investment in healthcare startups and rising initiatives from
government authorities to develop cost effective and safe drugs are some of the important market drivers in
this region. On the other hand, Asia Pacific anticipated emerging as most lucrative region by growing at
highest CAGR in the years to come. This is due sophisticated healthcare infrastructure in this region as well as
growing cancer population along with increasing incidences of metabolic disorders.
Infinium Global Research